Last reviewed · How we verify
HTX-011
At a glance
| Generic name | HTX-011 |
|---|---|
| Also known as | Zynrelef, Cohort 1, Cohort 2 |
| Sponsor | Heron Therapeutics |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Evaluation of the Efficacy and Safety of HTX-011 for Postoperative Analgesia Following Abdominoplasty Surgery (PHASE2)
- Bunionectomy Study for Postoperative Analgesia (EPOCH 1) (PHASE3)
- Total Knee Arthroplasty Infiltration Study for Postoperative Analgesia (PHASE2)
- Phase 2 Herniorrhaphy Study for Opioid Elimination (PHASE2)
- Phase 2B Upper Extremity Nerve Block Study (PHASE2)
- Phase 3 Herniorrhaphy Study for Postoperative Analgesia (EPOCH 2) (PHASE3)
- Total Knee Arthroplasty (TKA) Study of HTX-011 in an Multimodal Analgesic Regimen (MMA) Regimen (PHASE3)
- Pilot Herniorrhaphy Study for Postoperative Analgesia (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |